日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer

CREB结合蛋白/P300溴结构域抑制剂可减少中性粒细胞聚集并激活三阴性乳腺癌的抗肿瘤免疫

Xueying Yuan ,Xiaoxin Hao ,Hilda L Chan ,Na Zhao ,Diego A Pedroza ,Fengshuo Liu ,Kang Le ,Alex J Smith ,Sebastian J Calderon ,Nadia Lieu ,Michael J Soth ,Philip Jones ,Xiang Hf Zhang ,Jeffrey M Rosen

CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC

CBP/P300 BRD 抑制剂可减少中性粒细胞积聚并激活 TNBC 中的抗肿瘤免疫

Xueying Yuan, Xiaoxin Hao, Hilda L Chan, Na Zhao, Diego A Pedroza, Fengshuo Liu, Kang Le, Alex J Smith, Sebastian J Calderon, Nadia Lieu, Michael J Soth, Philip Jones, Xiang H-F Zhang, Jeffrey M Rosen

Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

靶向 eIF4A 可触发干扰素反应,与化疗产生协同作用并抑制三阴性乳腺癌

Na Zhao, Elena B Kabotyanski, Alexander B Saltzman, Anna Malovannaya, Xueying Yuan, Lucas C Reineke, Nadia Lieu, Yang Gao, Diego A Pedroza, Sebastian J Calderon, Alex J Smith, Clark Hamor, Kazem Safari, Sara Savage, Bing Zhang, Jianling Zhou, Luisa M Solis, Susan G Hilsenbeck, Cheng Fan, Charles M P

Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

靶向 EIF4A 可触发干扰素反应,与化疗产生协同作用并抑制三阴性乳腺癌

Na Zhao, Elena B Kabotyanski, Alexander B Saltzman, Anna Malovannaya, Xueying Yuan, Lucas C Reineke, Nadia Lieu, Yang Gao, Diego A Pedroza, Sebastian J Calderon, Alex J Smith, Clark Hamor, Kazem Safari, Sara Savage, Bing Zhang, Jianling Zhou, Luisa M Solis, Susan G Hilsenbeck, Cheng Fan, Charles M P